Evaluation of a Treatment and Education Programme for Type 1 Diabetic Patients (PRIMAS) (PRIMAS)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Norbert Hermanns, Forschungsinstitut der Diabetes Akademie Mergentheim
ClinicalTrials.gov Identifier:
NCT01220557
First received: October 12, 2010
Last updated: August 8, 2014
Last verified: August 2014
Results First Received: August 8, 2014  
Study Type: Interventional
Study Design: Allocation: Randomized;   Intervention Model: Parallel Assignment;   Masking: Open Label;   Primary Purpose: Treatment
Condition: Type 1 Diabetes
Interventions: Behavioral: PRIMAS
Behavioral: DTTP

  Participant Flow
  Hide Participant Flow

Recruitment Details
Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations
The participants were recruited in 23 outpatient study centres, which were located all over Germany. A study centre was defined as a medical practice run by a diabetologist and a diabetes educator or diabetes nurse.

Pre-Assignment Details
Significant events and approaches for the overall study following participant enrollment, but prior to group assignment
No text entered.

Reporting Groups
  Description
PRIMAS Group PRIMAS is a newly developed treatment and education programme for type 1 diabetic patients. It consists of 12 lessons (duration 90 minutes each), slides for diabetes educators and patient material
Control Group The German DTTP (Diabetes Teaching and Treatment Programme) - The German ZI Program - is an established treatment and education programme for intensified insulin treatment consisting of 12 lessons (90 minutes duration each). Flipchart for diabetes educators and patient material.

Participant Flow:   Overall Study
    PRIMAS Group   Control Group
STARTED   81   79 
COMPLETED   75 [1]   74 [1] 
NOT COMPLETED   6   5 
Lost to Follow-up                5                3 
attended less than 6 lessons                1                2 
[1] per protocol analysis including patients which participated in at least 6 out of 12 lessons.



  Baseline Characteristics
  Hide Baseline Characteristics

Population Description
Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate.
No text entered.

Reporting Groups
  Description
PRIMAS Group PRIMAS is a newly developed treatment and education programme for type 1 diabetic patients. It consists of 12 lessons (duration 90 minutes each), slides for diabetes educators and patient material
Control Group The German DTTP (Diabetes Teaching and Treatment Programme) - The German ZI Program - is an established treatment and education programme for intensified insulin treatment consisting of 12 lessons (90 minutes duration each). Flipchart for diabetes educators and patient material.
Total Total of all reporting groups

Baseline Measures
   PRIMAS Group   Control Group   Total 
Overall Participants Analyzed 
[Units: Participants]
 81   79   160 
Age 
[Units: Participants]
     
<=18 years   0   0   0 
Between 18 and 65 years   74   77   151 
>=65 years   7   2   9 
Age 
[Units: Years]
Mean (Standard Deviation)
 45.9  (13.8)   45.1  (13.4)   45.5  (13.5) 
Gender 
[Units: Participants]
     
Female   31   39   70 
Male   50   40   90 
Region of Enrollment 
[Units: Participants]
     
Germany   81   79   160 


  Outcome Measures

1.  Primary:   Changes in Glycemic Control Measured by A1c   [ Time Frame: 6 month ]

2.  Secondary:   Diabetes Knowledge   [ Time Frame: 6 month ]
Results not yet reported.   Anticipated Reporting Date:   No text entered.  

3.  Secondary:   Hypoglycaemia Awareness Score   [ Time Frame: 6 month ]
Results not yet reported.   Anticipated Reporting Date:   No text entered.  

4.  Secondary:   Diabetes Empowerment Score (DES)   [ Time Frame: 6 month follow up ]
Results not yet reported.   Anticipated Reporting Date:   No text entered.  

5.  Secondary:   Summary of Diabetes Self-Care Activities (SDSCA)   [ Time Frame: 6 month ]
Results not yet reported.   Anticipated Reporting Date:   No text entered.  

6.  Secondary:   Diabetes Distress Scale (DDS)   [ Time Frame: 6 month follow up ]
Results not yet reported.   Anticipated Reporting Date:   No text entered.  

7.  Secondary:   CES-D Score   [ Time Frame: 6 month follow up ]
Results not yet reported.   Anticipated Reporting Date:   No text entered.  

8.  Secondary:   Diabetes Self-Efficacy Scale   [ Time Frame: 6 Month Follow up ]
Results not yet reported.   Anticipated Reporting Date:   No text entered.  

9.  Secondary:   Treatment Satisfaction / Problem Areas in Dealing With Diabetes   [ Time Frame: 6 Month Follow up ]
Results not yet reported.   Anticipated Reporting Date:   No text entered.  

10.  Secondary:   Evaluation of the Diabetes Education Course   [ Time Frame: 6 month Follow up ]
Results not yet reported.   Anticipated Reporting Date:   No text entered.  


  Serious Adverse Events


  Other Adverse Events


  Limitations and Caveats
  Hide Limitations and Caveats

Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data
No text entered.


  More Information
  Hide More Information

Certain Agreements:  
All Principal Investigators ARE employed by the organization sponsoring the study.


Results Point of Contact:  
Name/Title: Norbert Hermanns, PhD
Organization: Forschungsinstitut der Diabetes Akademie Mergentheim
phone: +49 7931 594 ext 553
e-mail: hermanns@diabetes-zentrum.de


Publications of Results:

Responsible Party: Norbert Hermanns, Forschungsinstitut der Diabetes Akademie Mergentheim
ClinicalTrials.gov Identifier: NCT01220557     History of Changes
Other Study ID Numbers: NH062010
Study First Received: October 12, 2010
Results First Received: August 8, 2014
Last Updated: August 8, 2014